# Anika Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Jan 27, 2026

- Company: [Anika Therapeutics, Inc.](/companies/anik.md) (CIK 898437)
- Form: SCHEDULE 13D/A
- Filed: 2026-01-27
- Accepted by EDGAR: Jan 27, 2026, 19:29 ET
- Period: not reported
- Accession: 0000902664-26-000511
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/898437/000090266426000511/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/898437/000090266426000511/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/898437/000090266426000511/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jan 27, 2026.
Source: SEC EDGAR, the filing index for accession 0000902664-26-000511. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.